1. Chen, Guolin, Mo, Shanshan, Yuan, Di. 2021. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma. In BioMed research international, 2021, 9911784. doi:10.1155/2021/9911784. https://pubmed.ncbi.nlm.nih.gov/34195286/
2. Xie, Liangpeng, Shu, Yufeng, Ye, Mingzhu, Li, Yapei. 2024. Identification of MTCH1 as a novel prognostic indicator and therapeutic target in hepatocellular carcinoma. In Pathology, research and practice, 259, 155358. doi:10.1016/j.prp.2024.155358. https://pubmed.ncbi.nlm.nih.gov/38820930/
3. Nelo-Bazán, María Alejandra, Latorre, Pedro, Bolado-Carrancio, Alfonso, Rodríguez-Rey, José Carlos, Carrodeguas, José Alberto. 2015. Early growth response 1 (EGR-1) is a transcriptional regulator of mitochondrial carrier homolog 1 (MTCH 1)/presenilin 1-associated protein (PSAP). In Gene, 578, 52-62. doi:10.1016/j.gene.2015.12.014. https://pubmed.ncbi.nlm.nih.gov/26692143/
4. Ali, Ehab M M, Sonbul, Sultan N, Almuhaini, Eman A, Al-Ghafari, Ayat B. . Synergetic effect of doxorubicin and avenanthramide C on VDAC2/MTCH1 mitochondrial axis in breast cancer cells. In International journal of health sciences, 19, 26-41. doi:. https://pubmed.ncbi.nlm.nih.gov/40046789/
5. Liu, Xuan, Trakooljul, Nares, Hadlich, Frieder, Wimmers, Klaus, Ponsuksili, Siriluck. 2016. MicroRNA-mRNA regulatory networking fine-tunes the porcine muscle fiber type, muscular mitochondrial respiratory and metabolic enzyme activities. In BMC genomics, 17, 531. doi:10.1186/s12864-016-2850-8. https://pubmed.ncbi.nlm.nih.gov/27485725/
6. Wang, Li, Gong, Wei-Hua. . Predictive model using four ferroptosis-related genes accurately predicts gastric cancer prognosis. In World journal of gastrointestinal oncology, 16, 2018-2037. doi:10.4251/wjgo.v16.i5.2018. https://pubmed.ncbi.nlm.nih.gov/38764813/
7. De Angelis, Paula M, Svendsrud, Debbie H, Kravik, Katherine L, Stokke, Trond. 2006. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. In Molecular cancer, 5, 20. doi:. https://pubmed.ncbi.nlm.nih.gov/16709241/